These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35963838)

  • 1. Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in The Netherlands.
    Velikanova R; van der Schans S; Bischof M; van Olden RW; Postma M; Boersma C
    Value Health; 2022 Oct; 25(10):1696-1704. PubMed ID: 35963838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in England.
    Weidlich D; Servais L; Kausar I; Howells R; Bischof M
    Neurol Ther; 2023 Aug; 12(4):1205-1220. PubMed ID: 37222861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability in Newborn Screening Across Canada: Spinal Muscular Atrophy and Beyond.
    Groulx-Boivin E; Osman H; Chakraborty P; Lintern S; Oskoui M; Selby K; Van Caeseele P; Wyatt A; McMillan HJ
    Can J Neurol Sci; 2024 Mar; 51(2):203-209. PubMed ID: 36892082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for spinal muscular atrophy with disease-modifying therapies: a cost-effectiveness analysis.
    Shih ST; Farrar MA; Wiley V; Chambers G
    J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1296-1304. PubMed ID: 34321343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One Year of Newborn Screening for SMA - Results of a German Pilot Project.
    Vill K; Kölbel H; Schwartz O; Blaschek A; Olgemöller B; Harms E; Burggraf S; Röschinger W; Durner J; Gläser D; Nennstiel U; Wirth B; Schara U; Jensen B; Becker M; Hohenfellner K; Müller-Felber W
    J Neuromuscul Dis; 2019; 6(4):503-515. PubMed ID: 31594245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy.
    Ke Q; Zhao ZY; Mendell JR; Baker M; Wiley V; Kwon JM; Alfano LN; Connolly AM; Jay C; Polari H; Ciafaloni E; Qi M; Griggs RC; Gatheridge MA
    World J Pediatr; 2019 Jun; 15(3):219-225. PubMed ID: 30904991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn Screening for Spinal Muscular Atrophy: A 2.5-Year Experience in Hyogo Prefecture, Japan.
    Sonehara S; Bo R; Nambu Y; Iketani K; Lee T; Shimomura H; Ueda M; Takeshima Y; Iijima K; Nozu K; Nishio H; Awano H
    Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening for spinal muscular atrophy in Osaka -challenges in a Japanese pilot study.
    Kimizu T; Ida S; Oki K; Shima M; Nishimoto S; Nakajima K; Ikeda T; Mogami Y; Yanagihara K; Matsuda K; Nishi E; Hasegawa Y; Nozaki M; Fujita H; Irie A; Katayama T; Okamoto N; Imai K; Nishio H; Suzuki Y
    Brain Dev; 2023 Aug; 45(7):363-371. PubMed ID: 36973114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go.
    Dangouloff T; Vrščaj E; Servais L; Osredkar D;
    Neuromuscul Disord; 2021 Jun; 31(6):574-582. PubMed ID: 33985857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn Screening for Spinal Muscular Atrophy: Ontario Testing and Follow-up Recommendations.
    McMillan HJ; Kernohan KD; Yeh E; Amburgey K; Boyd J; Campbell C; Dowling JJ; Gonorazky H; Marcadier J; Tarnopolsky MA; Vajsar J; MacKenzie A; Chakraborty P
    Can J Neurol Sci; 2021 Jul; 48(4):504-511. PubMed ID: 33059774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn screening for spinal muscular atrophy - what have we learned?
    De Siqueira Carvalho AA; Tychon C; Servais L
    Expert Rev Neurother; 2023; 23(11):1005-1012. PubMed ID: 37635694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of spinal muscular atrophy newborn screening based on real-world data in Belgium.
    Dangouloff T; Thokala P; Stevenson MD; Deconinck N; D'Amico A; Daron A; Delstanche S; Servais L; Hiligsmann M
    Neuromuscul Disord; 2024 Jan; 34():61-67. PubMed ID: 38150893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The implementation of newborn screening for spinal muscular atrophy: the Australian experience.
    Kariyawasam DST; Russell JS; Wiley V; Alexander IE; Farrar MA
    Genet Med; 2020 Mar; 22(3):557-565. PubMed ID: 31607747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplex Real-Time PCR-Based Newborn Screening for Severe Primary Immunodeficiency and Spinal Muscular Atrophy in Osaka, Japan: Our Results after 3 Years.
    Kimizu T; Nozaki M; Okada Y; Sawada A; Morisaki M; Fujita H; Irie A; Matsuda K; Hasegawa Y; Nishi E; Okamoto N; Kawai M; Imai K; Suzuki Y; Wada K; Mitsuda N; Ida S
    Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving approaches to prenatal genetic counseling for Spinal Muscular Atrophy in the new treatment era.
    Zettler B; Estrella E; Liaquat K; Lichten L
    J Genet Couns; 2022 Jun; 31(3):803-814. PubMed ID: 35037741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial.
    Schwartz O; Vill K; Pfaffenlehner M; Behrens M; Weiß C; Johannsen J; Friese J; Hahn A; Ziegler A; Illsinger S; Smitka M; von Moers A; Kölbel H; Schreiber G; Kaiser N; Wilichowski E; Flotats-Bastardas M; Husain RA; Baumann M; Köhler C; Trollmann R; Schwerin-Nagel A; Eisenkölbl A; Schimmel M; Fleger M; Kauffmann B; Wiegand G; Baumgartner M; Rauscher C; Cirak S; Gläser D; Bernert G; Hagenacker T; Goldbach S; Probst-Schendzielorz K; Lochmüller H; Müller-Felber W; Schara-Schmidt U; Walter MC; Kirschner J; Pechmann A;
    JAMA Pediatr; 2024 Jun; 178(6):540-547. PubMed ID: 38587854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan.
    Noguchi Y; Bo R; Nishio H; Matsumoto H; Matsui K; Yano Y; Sugawara M; Ueda G; Wijaya YOS; Niba ETE; Shinohara M; Bouike Y; Takeuchi A; Okamoto K; Saito T; Shimomura H; Lee T; Takeshima Y; Iijima K; Nozu K; Awano H
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific guidelines and standard operating procedures for the molecular diagnosis.
    Abiusi E; Vaisfeld A; Fiori S; Novelli A; Spartano S; Faggiano MV; Giovanniello T; Angeloni A; Vento G; Santoloci R; Gigli F; D'Amico A; Costa S; Porzi A; Panella M; Ticci C; Daniotti M; Sacchini M; Boschi I; Dani C; Agostiniani R; Bertini E; Lanzone A; Lamarca G; Genuardi M; Pane M; Donati MA; Mercuri E; Tiziano FD;
    J Med Genet; 2023 Jul; 60(7):697-705. PubMed ID: 36414255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic literature review of the economic burden of spinal muscular atrophy and economic evaluations of treatments.
    Dangouloff T; Botty C; Beaudart C; Servais L; Hiligsmann M
    Orphanet J Rare Dis; 2021 Jan; 16(1):47. PubMed ID: 33485382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expert consensus on newborn screening for spinal muscular atrophy (2023 edition)].
    ;
    Zhonghua Yi Xue Za Zhi; 2023 Jul; 103(27):2075-2081. PubMed ID: 37455125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.